Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Sola

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cellular Signalling|March 5, 2018
STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphomaHadjer Miloudi, Karen Leroy, Fabrice Jardin, et al.
BMC Cancer|April 17, 2015
Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathwaySophie Bustany, Julie Cahu, Philippe Guardiola, et al.
Experimental Cell Research|May 15, 2007
Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytesCéline Lévêque, Véronique Marsaud, Jack-Michel Renoir, et al.
BMC Cancer|October 7, 2006
Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphomaSophie Krieger, Juliette Gauduchon, Mikel Roussel, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 9, 2009
Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cellsCéline Kerros, Thibault Cavey, Brigitte Sola, et al.
Journal of Neuroimmunology|February 19, 2010
Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cellsCéline Kerros, Isabelle Brood, Brigitte Sola, et al.
Journal of Hematology & Oncology|February 16, 2017
XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapyVincent Camus, Hadjer Miloudi, Antoine Taly, et al.
Journal of Hematology & Oncology|April 23, 2015
Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosisSophie Bustany, Julie Cahu, Géraldine Descamps, et al.
Journal of Molecular Endocrinology|March 5, 2008
Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cellsJack-Michel Renoir, Céline Bouclier, Amélie Seguin, et al.
Cells|October 29, 2020
ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell ResistanceMélody Caillot, Florence Zylbersztejn, Elsa Maitre, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cellular Signalling|March 5, 2018
STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphomaHadjer Miloudi, Karen Leroy, Fabrice Jardin, et al.
BMC Cancer|April 17, 2015
Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathwaySophie Bustany, Julie Cahu, Philippe Guardiola, et al.
Experimental Cell Research|May 15, 2007
Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytesCéline Lévêque, Véronique Marsaud, Jack-Michel Renoir, et al.
BMC Cancer|October 7, 2006
Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphomaSophie Krieger, Juliette Gauduchon, Mikel Roussel, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 9, 2009
Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cellsCéline Kerros, Thibault Cavey, Brigitte Sola, et al.
Journal of Neuroimmunology|February 19, 2010
Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cellsCéline Kerros, Isabelle Brood, Brigitte Sola, et al.
Journal of Hematology & Oncology|February 16, 2017
XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapyVincent Camus, Hadjer Miloudi, Antoine Taly, et al.
Journal of Hematology & Oncology|April 23, 2015
Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosisSophie Bustany, Julie Cahu, Géraldine Descamps, et al.
Journal of Molecular Endocrinology|March 5, 2008
Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cellsJack-Michel Renoir, Céline Bouclier, Amélie Seguin, et al.
Cells|October 29, 2020
ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell ResistanceMélody Caillot, Florence Zylbersztejn, Elsa Maitre, et al.
Pageof 5